NIH Phase I STTR Grant Awarded August 2023 for the Gelbrane

Blotting Innovations, with the support of NIH's Phase I STTR grant, is currently developing the Gelbrane. This innovative product, a precast polyacrylamide gel combined with a transfer membrane and a transfer apparatus, is not only efficient but also affordable, ensuring its accessibility to all researchers.  

A significant error-prone step in western blotting is the construction of a "transfer sandwich," where a membrane, blotter paper, and sponges are manually arranged around the gel following electrophoresis. Errors here often result in a completely failed experiment only discovered after ~2-3 days, causing sample loss, increased labor, lost time, and poor reproducibility.  

The Gelbrane is a revolutionary product that addresses this need. It eliminates the error-prone manual transfer sandwich construction step, thereby reducing the risk of failed experiments and the associated sample loss, labor, and time. Moreover, it is designed to be affordable and familiar to investigators, making it a valuable addition to any laboratory.